Sleep Apnea and Weight Loss Medication in Illinois
Obstructive sleep apnea (OSA) and obesity often occur together, and excess weight is one of the main risk factors for OSA. In late 2024 the FDA approved a weight loss medication for sleep apnea in adults with obesity. This guide explains the link and how treatment can fit together.
Important safety information. This page is general education, not medical advice. Only a licensed clinician who knows your history can decide whether a medication is right for you. Do not start, stop or change a prescription without talking to your clinician. If you have severe abdominal pain, trouble breathing, swelling of the face or throat, or thoughts of harming yourself, seek emergency care or call 988.
How Weight Affects Sleep Apnea
Extra weight, especially around the neck and upper airway, can contribute to the airway collapsing during sleep. OSA is linked with daytime fatigue, high blood pressure and other cardiovascular risks, and many people with it are undiagnosed. Diagnosis requires a sleep evaluation.
FDA-Approved Treatment With Tirzepatide
In December 2024 the FDA approved tirzepatide (Zepbound) to treat moderate-to-severe obstructive sleep apnea in adults with obesity, used with a reduced-calorie diet and increased physical activity. In the SURMOUNT-OSA trials, people taking tirzepatide had substantially fewer breathing interruptions per hour of sleep than those taking placebo. Individual results vary.
Medication Does Not Replace Other Care
Treatments such as CPAP, oral appliances or surgery remain important, and you should not stop CPAP or change your sleep treatment without talking to your sleep clinician. Medication is an added option that targets weight, a driver of OSA for many people.
Cost and Coverage
Coverage can differ when a medication is prescribed for sleep apnea rather than weight loss alone. Check your plan, and see insurance coverage and medication costs in Illinois.
Talking to a TeleSlim Clinic Physician
A TeleSlim Clinic physician can review your sleep diagnosis, history and goals by secure video visit from anywhere in Illinois and discuss whether treatment is appropriate. See semaglutide vs tirzepatide and how to choose a medication.
Frequently Asked Questions
Is Zepbound approved for sleep apnea?
Yes. The FDA approved tirzepatide (Zepbound) for moderate-to-severe obstructive sleep apnea in adults with obesity, as an addition to diet and activity.
Can I stop using my CPAP if I lose weight?
Not on your own. Only your sleep clinician can decide, usually after repeat testing.
Do I need a sleep study first?
Sleep apnea is diagnosed by a clinician, often with a sleep study. Your prescriber will tell you what documentation is needed.
How TeleSlim Clinic Can Help
A TeleSlim Clinic physician can review your health history and goals by secure video visit and discuss whether prescription weight loss treatment is appropriate for you. Prescribing is always at the clinician's discretion, and not every medication is right for every person. See our Cost & Insurance guides and Illinois locations.
Cost & Insurance guides
TeleSlim Clinic visits are self-pay, and we do not bill insurance for our own services. We do handle prior authorization for your medication, provide a superbill you can submit to your insurance for possible reimbursement, and send your medication and lab orders to the pharmacy or lab you choose, where your insurance can be used. We do not see patients with Medicare.
- Weight Loss Medication Cost in Illinois
- Insurance and Weight Loss Medication in Illinois
- Illinois Medicaid and Weight Loss Medication
- TeleSlim Clinic Pricing and Plans
- HSA and FSA for Weight Loss Treatment
- Cash-Pay vs. Insurance for Weight Loss Treatment
- Blue Cross Blue Shield of Illinois and Weight Loss Medication
- Illinois State Employee Plan and Weight Loss Medication
- When Your Employer Plan Excludes Weight Loss Drugs
- Prior Authorization and Appeals for Weight Loss Medication
- Self-Pay Weight Loss Medication and Compounded Drugs
- What to Ask Your Insurance About Weight Loss Medication
Medications & Decision Guides
Learn about the prescription options and how to choose:
- Semaglutide (Wegovy)
- Tirzepatide (Zepbound)
- Liraglutide (Saxenda)
- Phentermine-Topiramate (Qsymia)
- Naltrexone-Bupropion (Contrave)
- Setmelanotide (Imcivree)
- Orlistat (Xenical, alli)
- Semaglutide vs Tirzepatide
- Wegovy vs Zepbound
- Telehealth vs In-Person Care
- Medication vs Bariatric Surgery
- How to Choose a Medication
Weight Loss Guides by Health Condition
More in This Library
- PCOS and Weight Loss
- Prediabetes and Weight Loss
- Menopause Weight Gain
- Weight Regain After Bariatric Surgery
Start Your Weight Loss Journey
Free visit available — book your free visit.
If you are considering bariatric surgery, learn about surgical options with Dr. Jihad Kudsi at DoctorKudsi.com (https://www.doctorkudsi.com).
Sources: FDA approval of Zepbound for obstructive sleep apnea (December 2024); SURMOUNT-OSA, N Engl J Med 2024; Zepbound prescribing information.
This page is general information, not medical advice. Prescribing information changes; confirm current details with your clinician or pharmacist. Last updated: October 7, 2026.